Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells
Metabolic flexibility helps cancer cells survive targeted therapy, and BRAF-mutant melanoma rewires mitochondrial metabolism in response to BRAF/MEK inhibitors (BRAF/MEKi). We previously showed that connexin43 (Cx43) acts as a tumour suppressor in BRAF-mutant melanoma and enhances the response to BRAF/MEKi. Here, we investigated whether mitochondrial remodelling contributes to these effects. Cx43…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.